RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis"
Did you look at the research that Deitsch claimed Nutra published - Cobratoxin inhibits pain-evoked discharge of neurons in thalamic parafascicular nucleus in rats: Involvement of cholinergic and serotonergic systems